Google Trends Analysis of Interest in Pediatric Myopia-Control Spectacle Lenses Following FDA Authorization of Essilor Stellest

Document Type

Journal Article

Publication Date

6-1-2026

Journal

Cureus

Volume

18

Issue

6

DOI

10.7759/cureus.110127

Keywords

defocus incorporated multiple segments; digital epidemiology; essilor stellest; fda authorization; google search trends; interrupted time series; myopia control; myopia-control spectacle lenses; pediatric myopia; public interest

Abstract

PURPOSE: To quantify changes in US public interest in pediatric myopia-control spectacle lenses surrounding the U.S. Food and Drug Administration (FDA) authorization of Essilor Stellest (Essilor, Charenton-le-Pont, France) (September 25, 2025). METHODS: Weekly U.S. Google Trends relative search volume (RSV) data were collected for 2025 for parent-facing and brand-specific pediatric myopia-control spectacle lens search terms, with MiSight-related searches analyzed as a contemporaneous comparator. Search terms were selected a priori to capture both direct interest in the Stellest product and broader public interest in pediatric myopia-control spectacle lenses. A composite interest index was constructed by averaging RSV values for the following terms: "stellest", "stellest lenses", "essilor", "essilor stellest", "myopia control glasses", "pediatric myopia glasses", and "HALT lens". To account for general seasonality in children's eyewear searches, a baseline index was generated using the mean RSV of "kids glasses", "children's glasses", and "eyeglasses for kids", and a normalized interest ratio (composite ÷ baseline) was calculated. Pre- and post-authorization differences were compared using two-sided p-values. RESULTS: From 2025-01-05 to 2025-10-26 (37 pre- and six post-weeks), mean composite interest rose from 9.39 pre to 18.6 post (absolute +9.21, +98%; p = 0.024). The mean ratio to baseline increased from 0.353 to 0.694 (absolute +0.34, +96.3%; p = 0.016). MiSight-related searches remained stable over the same period, supporting a modality-specific response to Stellest authorization. CONCLUSIONS: Public search interest in pediatric myopia-control spectacle lenses increased markedly following FDA authorization of Essilor Stellest, with normalization suggesting growth beyond seasonal effects. These findings demonstrate increased online search activity surrounding pediatric myopia-control spectacles after authorization, which may help clinicians anticipate heightened patient and parent inquiries, although search interest does not directly reflect awareness, clinical adoption, or prescribing behavior.

Department

School of Medicine and Health Sciences Student Works

Share

COinS